A
3.86
-0.39 (-9.08%)
| Penutupan Terdahulu | 4.24 |
| Buka | 3.85 |
| Jumlah Dagangan | 4,405,993 |
| Purata Dagangan (3B) | 568,726 |
| Modal Pasaran | 1,203,350,400 |
| Harga / Pendapatan (P/E Ke hadapan) | 7.91 |
| Harga / Jualan (P/S) | 2.37 |
| Julat 52 Minggu |
| Margin Keuntungan | 16.42% |
| Margin Operasi (TTM) | 7.97% |
| EPS Cair (TTM) | 0.370 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 260.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -65.50% |
| Nisbah Semasa (MRQ) | 1.73 |
| Aliran Tunai Operasi (OCF TTM) | -148.89 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -216.76 M |
| Pulangan Atas Aset (ROA TTM) | 7.02% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Alvotech | Bercampur | Menurun |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.00 |
|
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 63.44% |
| % Dimiliki oleh Institusi | 6.44% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bracebridge Capital, Llc | 31 Mar 2026 | 2,705,304 |
| Littlejohn & Co Llc | 31 Mar 2026 | 1,318,534 |
| Oaktree Capital Management Lp | 31 Mar 2026 | 240,038 |
| Oaktree Fund Advisors, Llc | 31 Mar 2026 | 217,663 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |